Q2 2024 Holdings
Filed 2024-08-14 | 13 holdings | $428.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $124.3M | 10,360,945 | 29.0% |
| Alimera Sciences Inc | COM NEW | 016259202 | $93.6M | 16,835,154 | 21.9% |
| Anika Therapeutics Inc(ANIK) | COM | 035255108 | $36.4M | 1,435,993 | 8.5% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $34.3M | 1,525,730 | 8.0% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $28.4M | 4,598,737 | 6.6% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $26.7M | 1,843,756 | 6.2% |
| Evolus Inc(EOLS) | COM | 30052C107 | $23.5M | 2,167,790 | 5.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $22.2M | 514,711 | 5.2% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $13.5M | 1,042,889 | 3.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $8.7M | 745,758 | 2.0% |
| Y-Mabs Therapeutics Inc(YMABUSD) | COM | 984241109 | $7.0M | 582,078 | 1.6% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $5.6M | 3,374,791 | 1.3% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $3.7M | 500,000 | 0.9% |